Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer

NCT03801304

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CH Aix en Provence Aix-en-Provence, France
  • CHRU de Brest - Hôpital Morvan Brest, France
  • CLCC Caen Caen, France
  • CH de Créteil Créteil, France
View all 13 locations
View Trial Details
Completed

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

NCT04248829

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Eugenideio Therapeutirio - Ongcology Department Athens, Greece
  • Attikon Hospital Athens, Greece
  • Theageneio Anticancer Hospital of Thessaloniki Thessaloniki, Greece
View all 80 locations
View Trial Details
Completed

A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

NCT05867121

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • UCLA University of California Los Angeles Los Angeles, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • St Vincent'S Hospital Darlinghurst, New South Wales, Australia
View all 27 locations
View Trial Details
Completed

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NCT04623775

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Local Institution - 0160 Duarte, California, United States
  • Local Institution - 0081 Orange, California, United States
  • Local Institution - 0139 New Haven, Connecticut, United States
  • Local Institution - 0153 Jacksonville, Florida, United States
View all 125 locations
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details

Related conditions